SPTAN1 p.Asp2139=
c.6417C>T · rs140418358 · VCV378662
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -11 | GERP -4 |
| Overall | ||
| CADD | 6.392 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.193% | 519 |
| African / African-Americangrpmax | 0.0294% | 3,406 |
| Remaining individualsnot grpmax-eligible | 0.0272% | 3,676 |
| Admixed American | 0.02% | 5,001 |
| European (non-Finnish) | 0.00398% | 25,107 |
| South Asian | 0.00329% | 30,363 |
| East Asian | 0.00223% | 44,896 |
| Finnishnot grpmax-eligible | 0.00156% | 64,012 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SPTAN1
- Protein
- p.Asp2139=
- Coding
- c.6417C>T
- MANE Select
- NM_001130438
- dbSNP
- rs140418358
- Type
- single nucleotide variant
- Location
- chr9:128626528 (GRCh38)
- Gene constraint
- LOEUF 0.222 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 77.05 · 7 PDB
- Residue 2139
- a UniProt-annotated variant site (in hmnd11; pathogenic; decreased protein levels in patient cells); a UniProt-annotated variant site (in devep; likely pathogenic); a UniProt-annotated variant site (in hmnd11; likely pathogenic; decreased protein levels in patient cells)
Similar variants
- SPTAN1 p.Asp2139Asn Uncertain significance ★ ⚠ same residue
- SPTAN1 p.Asp2139Gly Uncertain significance ★ ⚠ same residue
- SPTAN1 p.Arg139Ter Likely pathogenic ★★ same condition
- SPTAN1 p.Arg156Ter Pathogenic/Likely pathogenic ★★ same condition
- SPTAN1 p.Arg1610Trp Pathogenic/Likely pathogenic ★★ same condition
- SPTAN1 p.Arg2308Cys Pathogenic/Likely pathogenic ★★ same condition
- SPTAN1 p.Arg548Ter Pathogenic ★★ same condition
- SPTAN1 p.Glu2271Lys Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sptan1-p-asp2139 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown